A detailed history of Bellecapital International Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bellecapital International Ltd. holds 2,359 shares of MRK stock, worth $236,041. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,359
Previous 2,340 0.81%
Holding current value
$236,041
Previous $289,000 7.61%
% of portfolio
0.06%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$111.15 - $128.97 $2,111 - $2,450
19 Added 0.81%
2,359 $267,000
Q4 2023

Jan 22, 2024

SELL
$100.18 - $109.02 $9,116 - $9,920
-91 Reduced 3.74%
2,340 $255,000
Q3 2023

Oct 17, 2023

SELL
$102.95 - $114.33 $37,988 - $42,187
-369 Reduced 13.18%
2,431 $250,000
Q2 2023

Jul 07, 2023

SELL
$108.61 - $118.38 $74,940 - $81,682
-690 Reduced 19.77%
2,800 $323,000
Q2 2021

Jul 28, 2021

SELL
$70.31 - $77.77 $399,642 - $442,044
-5,684 Reduced 61.96%
3,490 $271,000
Q1 2021

Apr 13, 2021

SELL
$68.86 - $81.11 $207,681 - $244,627
-3,016 Reduced 24.74%
9,174 $707,000
Q4 2020

Jan 14, 2021

BUY
$71.77 - $79.65 $130,908 - $145,281
1,824 Added 17.6%
12,190 $997,000
Q3 2020

Oct 16, 2020

BUY
$73.18 - $82.95 $120,088 - $136,120
1,641 Added 18.81%
10,366 $860,000
Q2 2020

Jul 16, 2020

BUY
$70.42 - $80.13 $143,656 - $163,465
2,040 Added 30.52%
8,725 $675,000
Q1 2020

Apr 24, 2020

SELL
$63.36 - $87.82 $37,635 - $52,165
-594 Reduced 8.16%
6,685 $514,000
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $235,998 - $266,296
3,042 Added 71.8%
7,279 $662,000
Q3 2019

Oct 22, 2019

BUY
$76.08 - $82.93 $76,992 - $83,925
1,012 Added 31.38%
4,237 $357,000
Q2 2019

Jul 22, 2019

BUY
$69.84 - $81.59 $29,682 - $34,675
425 Added 15.18%
3,225 $270,000
Q4 2018

Feb 07, 2019

BUY
$65.24 - $75.71 $182,672 - $211,987
2,800 New
2,800 $214,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bellecapital International Ltd. Portfolio

Follow Bellecapital International Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bellecapital International Ltd. with notifications on news.